I think ANDS was planning a financing deal in late July and issued a “pump” PR with SVR12 data on six patients in order to facilitate it (#msg-52795551, #msg-52795076). The financing deal presumably failed to get off the ground in July because of general market conditions.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.